These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8118603
1. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Dobashi Y, Sugimura H, Sato A, Hirabayashi T, Kanda H, Kitagawa T, Kawaguchi N, Imamura T, Machinami R. Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603 [Abstract] [Full Text] [Related]
2. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL. Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [Abstract] [Full Text] [Related]
3. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048 [Abstract] [Full Text] [Related]
4. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H. Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413 [Abstract] [Full Text] [Related]
5. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD. Am J Pathol; 1996 May 15; 148(5):1531-41. PubMed ID: 8623922 [Abstract] [Full Text] [Related]
6. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. Bovée JV, Cleton-Jansen AM, Rosenberg C, Taminiau AH, Cornelisse CJ, Hogendoorn PC. J Pathol; 1999 Dec 15; 189(4):454-62. PubMed ID: 10629543 [Abstract] [Full Text] [Related]
7. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K, Ikenaga M, Kotoura Y, Sasaki MS. Anticancer Res; 1996 Dec 15; 16(4A):2009-15. PubMed ID: 8712735 [Abstract] [Full Text] [Related]
8. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis. Sakamoto A, Oda Y, Adachi T, Oshiro Y, Tamiya S, Tanaka K, Matsuda S, Iwamoto Y, Tsuneyoshi M. Mod Pathol; 2001 Apr 15; 14(4):343-9. PubMed ID: 11301351 [Abstract] [Full Text] [Related]
12. p53 Gene alterations and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Hurlimann J, Chaubert P, Benhattar J. Mod Pathol; 1994 May 15; 7(4):423-8. PubMed ID: 8066070 [Abstract] [Full Text] [Related]
13. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR, Lee YJ, Tsai JH. J Clin Endocrinol Metab; 1994 Feb 15; 78(2):483-91. PubMed ID: 8106638 [Abstract] [Full Text] [Related]
15. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Liu FS, Kohler MF, Marks JR, Bast RC, Boyd J, Berchuck A. Obstet Gynecol; 1994 Jan 15; 83(1):118-24. PubMed ID: 8272291 [Abstract] [Full Text] [Related]
19. [P53 gene mutation in gallbladder cancer]. Roa I, Melo A, Roa J, Araya J, Villaseca M, de Aretxabala X. Rev Med Chil; 2000 Mar 15; 128(3):251-8. PubMed ID: 10962865 [Abstract] [Full Text] [Related]